Hyderabad Nursing Home Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 18.72 Cr
as on 17-07-2024
- Company Age 51 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.50 Cr
as on 17-07-2024
- Satisfied Charges ₹ 79.44 Cr
as on 17-07-2024
- Revenue -25.63%
(FY 2023)
- Profit -34.44%
(FY 2023)
- Ebitda 39.38%
(FY 2023)
- Net Worth 3.58%
(FY 2023)
- Total Assets -0.46%
(FY 2023)
About Hyderabad Nursing Home
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 18.72 Cr.
The company currently has active open charges totaling ₹22.50 Cr. The company has closed loans amounting to ₹79.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chinimilli Bhavani, Aditya Mukta, and Aravind Mukta serve as directors at the Company.
- CIN/LLPIN
U85110TG1973PTC001610
- Company No.
001610
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 1973
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hyderabad Nursing Home?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chinimilli Bhavani | Director | 29-Jul-2019 | Current |
Aditya Mukta | Additional Director | 06-Dec-2021 | Current |
Aravind Mukta | Additional Director | 06-Dec-2021 | Current |
Financial Performance of Hyderabad Nursing Home.
Hyderabad Nursing Home Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.63% decrease. The company also saw a substantial fall in profitability, with a 34.44% decrease in profit. The company's net worth moved up by a moderate rise of 3.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hyderabad Nursing Home?
In 2023, Hyderabad Nursing Home had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 14 Jul 2023 | ₹22.50 Cr | Open |
Others Creation Date: 01 Dec 2021 | ₹17.50 Cr | Satisfied |
Others Creation Date: 04 Sep 2017 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Hyderabad Nursing Home?
Unlock and access historical data on people associated with Hyderabad Nursing Home, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Nursing Home, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Nursing Home's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.